Iran press/Iran news: Dr. Hassan AbolGhassemi, the head of 'Society for Children suffering from Blood Cancer', in an exclusive interview with Iran Press on Wednesday emphasized that Iranian researchers have managed to produce a great number of anti-cancer drugs in the country which makes us a pioneer in this area of medicine. Dr. AbolGhassemi said Iran leads the way in treatment of Cancer.
He added: "Iran has defied US sanctions by producing a wide range of drugs, including 'Nanojade', a medicinal drug for treatment of Thalassemia."
Related news:
US targets Iranians by choking off medicine and food imports: IRCS Head
Dr. AbolGhassemi added: "This drug is notably digestive and the patients' compliance is much higher with this pill compared with previous medications. Iran became the first country in the world, after the main producer of the medicine, to mass produce the medication for Thalassemia sufferers."
Asked to comment on the possibility of exporting the drug, Dr. AbolGhassemi said: "Given that Iran is just the second country in the world to manufacture this medicine, the prospects for exporting this drug are excellent".
For the first time Iranian biotechnology and nano-researchers have succeeded in producing 'Nanojade', a medicine which gets rid of excess iron in the human body.
'Nanojade' can be eaten in doses of 90, 180 or 360 milligrams by patients suffering from Thalassemia.
'Nanojade' is produced by 'Nano Hayat Darou', an Iranian biotechnology firm which produces pharmaceutical medicines and specialises in nanomedicine.
208/ 211 /103
Read more:
New Iranian medicine unveiled to fight overload of iron in Thalassemia patients
Sales of Iran's Nanotech products soar
The role of Iranian social security organization in exporting medicine
Iranian professor: 90% of medicines used in Iran are home made
